NCT02629003View on ClinicalTrials.gov

[11C]Cimbi-36 Dosimetry

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

October 10, 2018

Study Completion Date

October 10, 2018

Conditions
Healthy
Interventions
DRUG

[11C]Cimbi-36

DRUG

[11C]Cimbi-36-5

Trial Locations (1)

2100

Neurobiology Research Unit, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Gitte Moos Knudsen

OTHER

NCT02629003 - [11C]Cimbi-36 Dosimetry | Biotech Hunter | Biotech Hunter